Aleks Radovic-Moreno, PhD, is a Partner at Longwood Fund, a Boston-based venture capital firm focused on life sciences. See sector focus and contact routes.
Aleks Radovic-Moreno, PhD, is a Partner at Longwood Fund, a Boston-based venture capital firm focused on life sciences company creation, where he also served as founding CEO of Weaver Therapeutics and co-founded Be Bio as its President. His investment thesis centers on early-stage ventures in engineered cell therapies, oncology, and gene therapy within the biotechnology and life sciences sectors. While specific check sizes and lead/follow behavior are not publicly detailed, his role emphasizes building and supporting portfolio companies from inception, often taking founding CEO or co-founder positions. Notable portfolio companies include Weaver Therapeutics (now Weaver Biosciences), Be Bio (Be Biopharma), Vor Biopharma, and Progentos Therapeutics, where he serves as a Board Member. Radovic-Moreno holds a distinctive point of view that prioritizes active company creation over passive investing, leveraging his PhD in Chemical and Biomedical Engineering from MIT and prior work in Robert Langer’s laboratory to drive novel therapeutic platforms. He is recognized for addressing unmet medical needs through drug discovery and innovative therapeutic modaliti
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Boston.
Investors like Aleks Radovic-Moreno · Full investor directory · Investor access · Company funding database